| Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review |
27 |
| Emerging respiratory infections: The infectious disease pathology of SARS, MERS, pandemic influenza, and Legionella |
23 |
| Emerging and reemerging fungal infections |
16 |
| Checkpoint inhibitor-induced liver injury: A novel form of liver disease emerging in the era of cancer immunotherapy |
14 |
| Four human diseases with significant public health impact caused by mosquito-borne flaviviruses: West Nile, Zika, dengue and yellow fever |
13 |
| Emerging agents of gastroenteritis: Aeromonas, Plesiomonas, and the diarrheagenic pathotypes of Escherichia coli |
9 |
| Hereditary SWI/SNF complex deficiency syndromes |
9 |
| Phosphaturic mesenchymal tumors: A review and update |
8 |
| Drug induced pseudolymphoma |
7 |
| Carbapenem-resistant Enterobacteriaceae: An emerging bacterial threat |
7 |
| Chagas disease as example of a reemerging parasite |
6 |
| Paraneoplastic syndromes: Definitions, classification, pathophysiology and principles of treatment |
6 |
| Cutaneous paraneoplastic syndromes |
6 |
| Pleomorphic liposarcoma: Updates and current differential diagnosis |
6 |
| Immunohistochemistry, carcinomas of unknown primary, and incidence rates |
6 |
| Non-neoplastic histiocytic and dendritic cell disorders in lymph nodes |
5 |
| Next generation immunohistochemistry: Emerging substitutes to genetic testing? |
5 |
| A pattern-based approach to reactive lymphadenopathies |
4 |
| Evaluation of the sick returned |
4 |
| Paraneoplastic syndromes and other systemic disorders associated with neuroendocrine neoplasms |
4 |
| Updates in spindle cell/pleomorphic lipomas |
4 |
| Diagnostic histochemistry in hepatic pathology |
4 |
| Iatrogenically false positive sentinel lymph nodes in breast cancer: Methods of recognition and evaluation |
4 |
| Iatrogenic pulmonary lesions |
4 |
| Metastases of malignant neoplasms: Historical, biological, & clinical considerations |
4 |
| Surviving at a distant site: The organotropism of metastatic breast cancer |
4 |
| Avoiding pitfalls in diagnostic immunohistochemistry-important technical aspects that every pathologist should know |
4 |
| In situ hybridization: Introduction to techniques, applications and pitfalls in the performance and interpretation of assays |
4 |
| Idiopathic noncirrhotic portal hypertension |
4 |
| Adipocytic tumors in Children: A contemporary review |
3 |
| Molecular updates in adipocytic neoplasms |
3 |
| Paraneoplastic neurological syndromes |
3 |
| Lipase hypersecretion syndrome: A distinct form of paraneoplastic syndrome specific to pancreatic acinar carcinomas |
3 |
| Emerging and re-emerging rickettsial infections |
3 |
| Diagnosis and management of metastatic neoplasms with unknown primary |
3 |
| In situ neoplasia in lymph node pathology |
3 |
| Hereditary gastrointestinal carcinomas and their precursors: An algorithm for genetic testing |
3 |
| The utility of bronchoalveolar lavage in the evaluation of interstitial lung diseases: A clinicopathological perspective |
2 |
| Hamartomas and malformations of the liver |
2 |
| Hamartomas of skin and soft tissue |
2 |
| Transboundary animal diseases as re-emerging threats - Impact on one health |
2 |
| Gynecological neoplasms associated with paraneoplastic hypercalcemia |
2 |
| A contemporary review of myxoid adipocytic tumors |
2 |
| Primary lesions that may imitate metastatic tumors histologically: A selective review |
2 |
| Wilson disease |
2 |
| Immunoglobulin G4-related hepatobiliary disease |
2 |
| Acute hepatitis and acute liver failure: Pathologic diagnosis and differential diagnosis |
1 |
| Pitfalls in molecular diagnostics |
1 |
| Reexamining post-transplant lymphoproliferative disorders: Newly recognized and enigmatic types |
1 |
| Iatrogenic pathology of the urinary bladder |
1 |
